Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines

NCT02184988 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
352
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Evolus, Inc.